Prevalence of infection in bilateral total hip arthroplasty: a comparison of single-stage 565 bilateral procedures performed with 1 or 2 sets of instruments

The Journal of Arthroplasty
Alejandro González Della ValleEduardo A Salvati

Abstract

Single-stage bilateral total hip arthroplasty can be performed with a completely new sterile setup for the second side or with the same instruments for both sides. The latter could theoretically lead to a higher prevalence of infection in the second side. We retrospectively determined the prevalence of deep infection during the first postoperative year in 271 consecutive patients operated on with different sterile setups (group 1) and 289 patients operated on with the same setup (group 2). There was one deep infection affecting the first side of a patient in group 1. In group 2, there were no deep infections (P is approximately 1.0) and one developed a superficial infection on the second side requiring readmission and intravenous antibiotics. Given the very low prevalence of deep infection of the first and second side (0.2% and 0%, respectively), it would be necessary to analyze more than 2,300 patients in each group to achieve statistical significance. Based on this experience, the use of the same set of instruments for the second side in the operating conditions described in this study appears safe.

References

Apr 1, 1976·Acta Orthopaedica Scandinavica·M A Ritter, J C Randolph
Jan 1, 1981·The Journal of Bone and Joint Surgery. British Volume·D Bracy, B M Wroblewski
Jun 4, 2002·The Journal of the American Academy of Orthopaedic Surgeons·William MacaulayPaul M Pellicci
Jan 21, 2003·The Journal of Bone and Joint Surgery. American Volume·Charlotte B PhillipsJeffrey N Katz

❮ Previous
Next ❯

Citations

Sep 4, 2010·Regional Anesthesia and Pain Medicine·Stavros G MemtsoudisNigel E Sharrock
Jan 27, 2010·Journal of Orthopaedic Trauma·Scott C FaucettKenneth J Koval
Nov 29, 2007·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Zoran PopovićAleksandar Radunović
Oct 11, 2007·The Journal of Arthroplasty·Keith R BerendJoanne B Adams
Apr 29, 2008·Arthritis and Rheumatism·Anne LübbekePierre Hoffmeyer
Apr 14, 2016·The Journal of Arthroplasty·Georgios K TriantafyllopoulosLazaros A Poultsides
Feb 12, 2017·Irish Journal of Medical Science·F R PowerP D Curtin
Jun 25, 2020·Arthroplasty Today·Jessica S MortonLazaros A Poultsides

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The Journal of Arthroplasty
J Alfaro-AdriánD W Murray
The New England Journal of Medicine
W H Harris, Clement B Sledge
© 2021 Meta ULC. All rights reserved